Coding Ahead
CasePilot
Medical Coding Assistant
Case2Code
Search and Code Lookup Tool
RedactPHI
HIPAA-Compliant PHI Redaction
DetectICD10CM
ICD-10-CM Code Detection
Log in Register free account
1 code page views remaining. Guest accounts are limited to 1 page view. Register free account to get 5 more views.
Log in Register free account

Official Description

Typhoid vaccine, Vi capsular polysaccharide (ViCPs), for intramuscular use

© Copyright 2025 American Medical Association. All rights reserved.

Common Language Description

The CPT® Code 90691 refers to the Typhoid vaccine, specifically the Vi capsular polysaccharide (ViCPs) formulation, which is administered via intramuscular injection. Vaccines, such as this one, are designed to provide active, long-term immunity by stimulating the recipient's immune system. Unlike immune globulins that offer short-term, passive immunity, vaccines expose the immune system to altered forms of specific pathogens, prompting it to produce its own antibodies. This process enables the body to "remember" how to generate these antibodies upon future exposure to the same antigen. Typhoid fever, caused by the bacterium Salmonella typhi, is characterized by symptoms such as high fever, rash, and diarrhea, and is transmitted through contaminated food, water, and milk. The use of this vaccine is crucial in preventing typhoid infection, particularly in areas where the disease is prevalent. It is important to note that there are different preparations of vaccines available for typhoid protection; for instance, code 90690 is designated for an oral vaccine that contains the live, actual virus, while code 90691 is specifically for the ViCPs vaccine intended for intramuscular use. These codes are utilized solely to report the specific vaccine product administered.

© Copyright 2025 Coding Ahead. All rights reserved.

1. Indications

The Typhoid vaccine, Vi capsular polysaccharide (ViCPs), is indicated for individuals who are at risk of contracting typhoid fever. This includes:

  • Travelers to Endemic Areas: Individuals traveling to regions where typhoid fever is common, particularly in developing countries with inadequate sanitation and hygiene practices.
  • Laboratory Personnel: Healthcare workers and laboratory personnel who may be exposed to Salmonella typhi in their work environment.
  • Individuals in Close Contact: People who live in or are in close contact with someone who has typhoid fever.

2. Procedure

The administration of the Typhoid vaccine, Vi capsular polysaccharide (ViCPs), involves several key procedural steps:

  • Step 1: Patient Assessment Prior to vaccination, a thorough assessment of the patient’s medical history and current health status is conducted to ensure they are suitable candidates for the vaccine. This includes checking for any contraindications or previous allergic reactions to vaccines.
  • Step 2: Preparation of the Vaccine The vaccine is prepared according to the manufacturer's instructions. This may involve shaking the vial to ensure the vaccine is well mixed and drawing the appropriate dose into a sterile syringe.
  • Step 3: Site Selection and Injection The healthcare provider selects an appropriate site for intramuscular injection, typically the deltoid muscle of the upper arm. The skin is cleaned with an antiseptic wipe to reduce the risk of infection. The vaccine is then injected into the muscle using a sterile technique.
  • Step 4: Post-Injection Monitoring After the injection, the patient is monitored for a short period to observe for any immediate adverse reactions. This is a standard precaution following vaccination.

3. Post-Procedure

Post-procedure care for the Typhoid vaccine, ViCPs, includes advising the patient on potential side effects, which may include soreness at the injection site, mild fever, or fatigue. Patients should be informed to report any unusual or severe reactions. It is also important to remind them about the need for booster doses as recommended, depending on their risk factors and travel plans. Documentation of the vaccination should be recorded in the patient's medical record, including the date of administration, vaccine lot number, and the site of injection.

Short Descr TYPHOID VACCINE IM
Medium Descr TYPHOID VACCINE VI CAPSULAR POLYSACCHARIDE IM
Long Descr Typhoid vaccine, Vi capsular polysaccharide (ViCPs), for intramuscular use
Related Drugs Typhim Vi
Status Code Excluded from Physician Fee Schedule by Regulation
Global Days XXX - Global Concept Does Not Apply
PC/TC Indicator (26, TC) 9 - Not Applicable
Multiple Procedures (51) 9 - Concept does not apply.
Bilateral Surgery (50) 9 - Concept does not apply.
Physician Supervisions 09 - Concept does not apply.
Assistant Surgeon (80, 82) 9 - Concept does not apply.
Co-Surgeons (62) 9 - Concept does not apply.
Team Surgery (66) 9 - Concept does not apply.
Diagnostic Imaging Family 99 - Concept Does Not Apply
APC Status Indicator Items and Services Packaged into APC Rates
ASC Payment Indicator Packaged service/item; no separate payment made.
Type of Service (TOS) 1 - Medical Care
Berenson-Eggers TOS (BETOS) O1G - Immunizations/Vaccinations
MUE 1
CCS Clinical Classification 228 - Prophylactic vaccinations and inoculations
GY Item or service statutorily excluded, does not meet the definition of any medicare benefit or, for non-medicare insurers, is not a contract benefit
GA Waiver of liability statement issued as required by payer policy, individual case
22 Increased procedural services: when the work required to provide a service is substantially greater than typically required, it may be identified by adding modifier 22 to the usual procedure code. documentation must support the substantial additional work and the reason for the additional work (ie, increased intensity, time, technical difficulty of procedure, severity of patient's condition, physical and mental effort required). note: this modifier should not be appended to an e/m service.
25 Significant, separately identifiable evaluation and management service by the same physician or other qualified health care professional on the same day of the procedure or other service: it may be necessary to indicate that on the day a procedure or service identified by a cpt code was performed, the patient's condition required a significant, separately identifiable e/m service above and beyond the other service provided or beyond the usual preoperative and postoperative care associated with the procedure that was performed. a significant, separately identifiable e/m service is defined or substantiated by documentation that satisfies the relevant criteria for the respective e/m service to be reported (see evaluation and management services guidelines for instructions on determining level of e/m service). the e/m service may be prompted by the symptom or condition for which the procedure and/or service was provided. as such, different diagnoses are not required for reporting of the e/m services on the same date. this circumstance may be reported by adding modifier 25 to the appropriate level of e/m service. note: this modifier is not used to report an e/m service that resulted in a decision to perform surgery. see modifier 57 for significant, separately identifiable non-e/m services, see modifier 59.
33 Preventive services: when the primary purpose of the service is the delivery of an evidence based service in accordance with a us preventive services task force a or b rating in effect and other preventive services identified in preventive services mandates (legislative or regulatory), the service may be identified by adding 33 to the procedure. for separately reported services specifically identified as preventive, the modifier should not be used.
59 Distinct procedural service: under certain circumstances, it may be necessary to indicate that a procedure or service was distinct or independent from other non-e/m services performed on the same day. modifier 59 is used to identify procedures/services, other than e/m services, that are not normally reported together, but are appropriate under the circumstances. documentation must support a different session, different procedure or surgery, different site or organ system, separate incision/excision, separate lesion, or separate injury (or area of injury in extensive injuries) not ordinarily encountered or performed on the same day by the same individual. however, when another already established modifier is appropriate it should be used rather than modifier 59. only if no more descriptive modifier is available, and the use of modifier 59 best explains the circumstances, should modifier 59 be used. note: modifier 59 should not be appended to an e/m service. to report a separate and distinct e/m service with a non-e/m service performed on the same date, see modifier 25.
AH Clinical psychologist
CC Procedure code change (use 'cc' when the procedure code submitted was changed either for administrative reasons or because an incorrect code was filed)
CR Catastrophe/disaster related
GC This service has been performed in part by a resident under the direction of a teaching physician
GX Notice of liability issued, voluntary under payer policy
GZ Item or service expected to be denied as not reasonable and necessary
JZ Zero drug amount discarded/not administered to any patient
RT Right side (used to identify procedures performed on the right side of the body)
SK Member of high risk population (use only with codes for immunization)
SL State supplied vaccine
TW Back-up equipment
UC Medicaid level of care 12, as defined by each state
Date
Action
Notes
2011-01-01 Changed Short description changed.
1999-01-01 Added First appearance in code book in 1999.
Code
Description
Code
Description
Code
Description
Code
Description
Code
Description
CasePilot

Get instant expert-level medical coding assistance.

Ask about:
CPT Codes Guidelines Modifiers Crosswalks NCCI Edits Compliance Medicare Coverage
Example: "What is CPT code 99213?" or "Guidelines for E/M services"